Navigation Links
Multiple Presentations Confirm Clinical Efficacy and High Rate of Patient Compliance Using Provent® Sleep Apnea Therapy to Treat Obstructive Sleep Apnea
Date:6/14/2011

BELMONT, Calif., June 14, 2011 /PRNewswire/ -- Ventus Medical, Inc. today announced that several independent board-certified sleep specialists presented positive clinical data supporting use of Provent® Sleep Apnea Therapy in their obstructive sleep apnea patients. These presentations, at SLEEP 2011, the 25th Annual Meeting of the Associated Professional Sleep Societies in Minneapolis, Minnesota, highlight the clinical efficacy and high compliance rate for patients with obstructive sleep apnea (OSA) using Provent Therapy.

(Photo: http://photos.prnewswire.com/prnh/20110209/SF45785-b)

(Photo: http://photos.prnewswire.com/prnh/20110209/SF45785-a)

"Together, these presentations provide conclusive evidence from clinical practices throughout the United States that Provent Therapy offers an effective treatment option for patients with obstructive sleep apnea who are not compliant on CPAP therapy," said Philip Westbrook, M.D., Chief Medical Officer of Ventus Medical and Emeritus Clinical Professor of Medicine at the University of California, Los Angeles. "In addition to the consistent evidence of reduced apnea hypopnea index (AHI) and Epworth sleepiness scale (ESS), the presentations today include positive long-term (12-month) Provent Therapy results. We are excited to see how Provent Therapy is being used by sleep specialists across the country and incorporated into their therapeutic protocols for untreated patients suffering from obstructive sleep apnea."

Oral Presentation Highlights Use of Provent Therapy over 12-Month Duration

Meir Kryger, M.D., of Gaylord Sleep Medicine in Wallingford, CT presented data from a 13-center, 12-month prospective study. Results showed that patients treated with Provent Therapy over a period of 12-months reduced their AHI by 70 percent. AHI is a measure of h
'/>"/>

SOURCE Ventus Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
2. Additional Data From Multiple Phase 1 and 2 Studies of S*BIOs Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis (MF)
3. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
4. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
5. Multiple Presentations Featuring QNEXA® Data to be Presented at the European Congress on Obesity
6. Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device
7. Study Determined Best Dose and Showed 55 Percent Response Rate With Lilly Anti-BAFF Monoclonal Antibody in Previously-Treated Multiple Myeloma Patients
8. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
9. Stereotaxis Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
10. Savient Pharmaceuticals to Present Multiple Abstracts at The European League Against Rheumatism (EULAR) 2011 Annual Congress
11. Reportlinker Adds Epidemiology: Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... and Chief Executive Officer, Doug Godshall , is ... Growth Conference at 8:30 a.m. EDT on Thursday, August ... 2015 at the InterContinental Boston. A live ...
(Date:8/4/2015)... Research and Markets ... the "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" report to ... 2020 - Focus on Patient Comfort and Operational ... the market, competitive landscape, and trends for three ...
(Date:8/4/2015)... 2015  Dr. Keesha Ewers of ... approval of flibanserin, or what is being touted ... of decreased female sexual desire back several decades. ... and addressing libido as a singular symptom with ... Photo - ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5
... Vical Incorporated,(Nasdaq: VICL ) today announced ... independently produced video report featuring metastatic,melanoma patients treated ... is expected to be used,broadly by stations in ... Allovectin-7(R) trial, and in other cities by stations ...
... III Results Demonstrate Superior Reduction in In-Segment Late Loss, Non-Inferiority in ... ... V Compared to TAXUS, ABBOTT PARK, Ill., April ... Association (JAMA) demonstrated,that use of Abbott,s XIENCE(TM) V Everolimus Eluting Coronary ...
Cached Medicine Technology:Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 2Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 3Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 4Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 5Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 2Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 3Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 4Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 5
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... to Los Angeles commercial customers. Finding reliable hardware can be difficult and ... When putting an office together or designing a new facility, it is ...
(Date:8/4/2015)... ... , ... Angelina Jolie is in it at age 39. “It” is menopause, ... Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the Southwest’s leading ... menopause. , Myth #1: Menopause only affects old ladies. – Menopause can affect ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... General of the United States, Richard Carmona, M.D., M.P.H., FACS, to its Board ... medication errors and will save lives," Dr. Carmona said. "I strongly believe in ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... School is ... summer in the sun and preparing for the back-to-school scramble. Dublin, OH family ... is the best time for the annual dental checkup. In fact, the dentist recently ...
(Date:8/4/2015)... Thailand (PRWEB) , ... August 04, 2015 , ... ... United Kingdom and other international locations have shown a rise in binge drinking ... consistent link between binge drinking and depression, are continuing to examine trends and ...
Breaking Medicine News(10 mins):Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3
... Plastic and Reconstructive Surgeon Kouros Azar, M.D. offers his ... Safety Awareness Week from March 8 to 14, 2009 sponsored ... safety and comfort are paramount to Dr. Azar , ... facilities located at 425 Haaland Drive, Suite 200 in Thousand ...
... of US citizens travel to Mexico for cancer treatment, ... is much less expensive, says TMD Unlimited, a medical ... Chronic Lymphocytic Leukemia (CLL), he went to three different ... In telling their story, the Teeters hope to help ...
... , , FRIDAY, March 13 (HealthDay News) -- Most kidney ... technique that eliminates the need for surgery, a pair ... findings have prompted the researchers to claim that the ... standard" of treatment for kidney cancer -- although not ...
... help women to take control of their health by ... Commission for Women and First Lady Judge Marjorie O. ... Wellness Guide kiosks in two Philadelphia-area Acme Markets. "Women ... themselves, and their own health ends up low on ...
... The human brain,s sensitivity to unexpected outcomes plays a ... behaviors, according to a new study by a team of ... a computer-based card game and microelectrodes to observe neuronal activity ... the journal Science , suggests that neurons in the ...
... the only Minnesota hospitals to receive designation ROCHESTER, Minn., ... Surgical Quality Improvement Program (ACS NSQIP) has recognized Mayo ... of the 26 ACS NSQIP participating hospitals in the ... patient care. As a participant in ACS NSQIP, Mayo ...
Cached Medicine News:Health News:Kouros Azar, M.D. (doctorazar.com), Noted Plastic and Reconstructive Surgeon, Offers Top 10 Tips to Patients to Help Celebrate National Patient Safety Awareness Week 2Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 2Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 3Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 4Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 5Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 6Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 7Health News:Freezing Kidney Cancers Shows Promise 2Health News:Freezing Kidney Cancers Shows Promise 3Health News:PA Commission For Women Kiosk Helps Women Access Health Information 2Health News:University of Pennsylvania researchers find that the unexpected is a key to human learning 2Health News:American College of Surgeons Recognizes Mayo Hospitals for Exemplary Outcomes 2Health News:American College of Surgeons Recognizes Mayo Hospitals for Exemplary Outcomes 3
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
... rHead Radial Implant System provides todays ... to radial head replacement. Modular ... patient anatomy while minimizing ligamentous and ... designed alignment guide assists in both ...
For connection to the bipolar output of electrosurgical generators....
This table has adjustable height, an integral leg, and blade post. Includes a standard 2" (5 cm) pad....
Medicine Products: